We are live on ! Find out more
RNAM

Avidity Biosciences
RNAM

Delisted

RNAM was delisted on the 26th of February, 2026.

Back to rankings

1 hedge funds and large institutions have $236K invested in Avidity Biosciences in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 335 closing their positions.

New
Increased
Maintained
Reduced
Closed

99.36% less ownership

Funds ownership: 99.37% → 0.01% (-99%)

100% less funds holding

Funds holding: 343 → 1 (-342)

100% less funds holding in top 10

Funds holding in top 10: 33 → 0 (-33)

100% less capital invested

Capital invested by funds: $10.8B → $236K (-$10.8B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 335

Holders
1
Holders Change
-342
Holders Change %
-99.71%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
-33
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
335
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$927M
2
RCM
RA Capital Management
Massachusetts
-$623M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$501M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$436M
5
PCM
Pentwater Capital Management
Florida
-$435M
Name Holding Trade Value Shares
Change 		Change in
Stake
IA
251
IFP Advisors
Florida
– -$287K -3,977 Closed
Amundi
252
Amundi
France
– -$284K -3,939 Closed
ZCP
253
Z3 Capital Partners
Virginia
– -$274K -3,800 Closed
Nisa Investment Advisors
254
Nisa Investment Advisors
Missouri
– -$263K -3,653 Closed
AB
255
Amalgamated Bank
New York
– -$262K -3,637 Closed
FFM
256
Forum Financial Management
Illinois
– -$253K -3,504 Closed
GI
257
GAMCO Investors
Connecticut
– -$252K -3,500 Closed
HNWAG
258
High Net Worth Advisory Group
Florida
– -$252K -3,500 Closed
RWM
259
Ritholtz Wealth Management
New York
– -$252K -3,488 Closed
Mitsubishi UFJ Asset Management
260
Mitsubishi UFJ Asset Management
Japan
– -$245K -3,396 Closed
KBC Group
261
KBC Group
Belgium
– -$243K -3,375 Closed
MG
262
Marex Group
– -$243K -3,371 Closed
EGM
263
Engineers Gate Manager
New York
– -$238K -3,298 Closed
QCG
264
Quadrant Capital Group
Ohio
– -$231K -3,196 Closed
FCM
265
Fieldview Capital Management
Michigan
– -$227K -3,149 Closed
VanEck Associates
266
VanEck Associates
New York
– -$220K -3,044 Closed
BC
267
BIT Capital
Germany
– -$216K -3,000 Closed
OGC
268
One68 Global Capital
New York
– -$216K -3,000 Closed
PAG
269
Private Advisor Group
New Jersey
– -$216K -3,000 Closed
SC
270
Shay Capital
New York
– -$216K -3,000 Closed
GFM
271
GF Fund Management
China
– -$214K -2,961 Closed
HHGC
272
Hunting Hill Global Capital
New York
– -$212K -2,937 Closed
ECSS
273
Eurizon Capital SGR SpA
– -$200K -2,778 Closed
Walleye Trading
274
Walleye Trading
New York
– -$180K -2,500 Closed
GI
275
GAMMA Investing
California
– -$178K -2,471 Closed
9 10
11
12 13

RNAM Hedge Fund Activity: Q1 2026 in Review

1 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Avidity Biosciences (RNAM) for Q1 2026, worth a combined $236K — down 100% from $10.8B a quarter earlier.

Sellers outnumbered buyers: 335 funds closed out of RNAM and 0 opened new positions — a net loss of 335 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $927M sold.

  • 1 institutional investor held Avidity Biosciences (RNAM) as of Q1 2026, down from 343 in Q4 2025.
  • Funds reported $236K of Avidity Biosciences stock for Q1 2026, down 100% quarter-over-quarter.
  • 0 funds opened new Avidity Biosciences positions in Q1 2026 and 335 closed out, a net change of -335 holders.
  • The largest Avidity Biosciences seller in Q1 2026 was BlackRock, an estimated $927M sold.

Based on aggregated 13F filings for Q1 2026.